Functions and Mechanisms of Diabetes-Linked Transcription Factors
Frontiers in Bioscience-Landmark · 27.08.2025 · 30 (8)
DOI: 10.31083/fbl36544 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 27.08.2025. Verfasst von Naveen K Parthiban und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia. Hauptthemen laut MEDLINE: Transcription Factors, Diabetes Mellitus, Type 2, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Transcription factors are significant regulators of gene expression in most biological processes related to diabetes, including beta cell (β-cell) development, insulin secretion and glucose metabolism. Dysregulation of transcription factor expression or abundance has been closely associated with the pathogenesis of type 1 and type 2 diabetes, including pancreatic and duodenal homeobox 1 (PDX1), neurogenic differentiation 1 (NEUROD1), and forkhead box protein O1 (FOXO1). Gene expression is regulated at the transcriptional level by transcription factor binding, epigenetically by DNA methylation and chromatin remodelling, and post-transcriptional mechanisms, including alternative splicing and microRNA (miRNA). Recent data indicate a central role for transcription factors in pancreatic β-cell failure in the context of systemic insulin resistance and chronic inflammation. Therapeutic modulation of transcription factor abundance via gene therapy, small-molecule pharmacology, and epigenetic therapies holds great promise for β-cell restoration and metabolic normalisation. However, further clinical translation will require targeted delivery to appropriate tissues, minimising off-target effects and ensuring long-term safety. This review focuses on the involvement of pancreatic β-cells and transcription factors in diabetes development and their therapeutic implications, intending to develop and consolidate a basis for further research in this area and for the treatment of diabetes in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Zitieren
APA
Parthiban, N. K., Nassif, N. T., & Simpson, A. M. (2025). Functions and Mechanisms of Diabetes-Linked Transcription Factors. Frontiers in Bioscience-Landmark, 30(8). https://doi.org/10.31083/fbl36544
Vancouver
Parthiban NK, Nassif NT, Simpson AM. Functions and Mechanisms of Diabetes-Linked Transcription Factors. Frontiers in Bioscience-Landmark. 2025;30(8). doi:10.31083/fbl36544
BibTeX
@article{Parthiban2025,
author = {Parthiban, Naveen K and Nassif, Najah T and Simpson, Ann M},
title = {Functions and Mechanisms of Diabetes-Linked Transcription Factors},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {8},
doi = {10.31083/fbl36544}
}
EUVIMED